Eli Lilly and Company (LLY.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 04:30PM CEST
| Previous close | 722.40 |
| Open | 717.40 |
| Bid | 706.00 x 30000 |
| Ask | 707.40 x 30000 |
| Day's range | 712.30 - 718.70 |
| 52-week range | 387.40 - 742.80 |
| Volume | |
| Avg. volume | 596 |
| Market cap | 676.973B |
| Beta (5Y monthly) | 0.37 |
| PE ratio (TTM) | 113.42 |
| EPS (TTM) | 6.28 |
| Earnings date | 08 Aug 2024 |
| Forward dividend & yield | 4.83 (0.67%) |
| Ex-dividend date | 15 May 2024 |
| 1y target est | N/A |
ZacksPharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Pfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA panel meeting to discuss Eli Lilly's (LLY) donanemab is set to take place on Jun 10.
Investor's Business DailyHow A Top Fund Beats The Market By Owning Future Leaders
Julianne McHugh, lead manager of best mutual fund BNY Mellon Large Cap Securities, isn't interested in blue-chip stars of yesteryear.
ZacksZacks Investment Ideas feature highlights: Eaton, Eli Lilly and Arista Networks
Eaton, Eli Lilly and Arista Networks have been highlighted in this Investment Ideas article.
© 2024 Yahoo. All rights reserved.